Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis M Mansky

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Retrovirology|March 25, 2016
Dual anti-HIV mechanism of clofarabineMichele B Daly, Megan E Roth, Laurent Bonnac, et al.
Bioorganic & Medicinal Chemistry|October 15, 2013
5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitorsJonathan M Rawson, Richard H Heineman, Lauren B Beach, et al.
Retrovirology|September 22, 2010
Biophysical analysis of HTLV-1 particles reveals novel insights into particle morphology and Gag stochiometryIwen F Grigsby, Wei Zhang, Jolene L Johnson, et al.
Plos One|January 26, 2011
Analysis of the ex vivo and in vivo antiretroviral activity of gemcitabineChristine L Clouser, Colleen M Holtz, Mary Mullett, et al.
Journal of Virology|April 27, 2018
Critical Role of the Human T-Cell Leukemia Virus Type 1 Capsid N-Terminal Domain for Gag-Gag Interactions and Virus Particle AssemblyJessica L Martin, Luiza M Mendonça, Rachel Marusinec, et al.
Biophysical Journal|March 16, 2011
Characterization of cytoplasmic Gag-gag interactions by dual-color z-scan fluorescence fluctuation spectroscopyKeir H Fogarty, Yan Chen, Iwen F Grigsby, et al.
ACS Chemical Biology|February 23, 2021
Inhibiting HTLV-1 Protease: A Viable Antiviral TargetGordon J Lockbaum, Mina Henes, Nathaniel Talledge, et al.
Journal of Molecular Biology|May 16, 2017
Single-Strand Consensus Sequencing Reveals that HIV Type but not Subtype Significantly Impacts Viral Mutation Frequencies and SpectraJonathan M O Rawson, Daryl M Gohl, Sean R Landman, et al.
Antimicrobial Agents and Chemotherapy|February 3, 2016
5-Azacytidine Enhances the Mutagenesis of HIV-1 by Reduction to 5-Aza-2'-DeoxycytidineJonathan M O Rawson, Michele B Daly, Jiashu Xie, et al.
Journal of Molecular Biology|May 7, 2023
HIV-2 Immature Particle Morphology Provides Insights into Gag Lattice Stability and Virus MaturationNathaniel Talledge, Huixin Yang, Ke Shi, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Retrovirology|March 25, 2016
Dual anti-HIV mechanism of clofarabineMichele B Daly, Megan E Roth, Laurent Bonnac, et al.
Bioorganic & Medicinal Chemistry|October 15, 2013
5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitorsJonathan M Rawson, Richard H Heineman, Lauren B Beach, et al.
Retrovirology|September 22, 2010
Biophysical analysis of HTLV-1 particles reveals novel insights into particle morphology and Gag stochiometryIwen F Grigsby, Wei Zhang, Jolene L Johnson, et al.
Plos One|January 26, 2011
Analysis of the ex vivo and in vivo antiretroviral activity of gemcitabineChristine L Clouser, Colleen M Holtz, Mary Mullett, et al.
Journal of Virology|April 27, 2018
Critical Role of the Human T-Cell Leukemia Virus Type 1 Capsid N-Terminal Domain for Gag-Gag Interactions and Virus Particle AssemblyJessica L Martin, Luiza M Mendonça, Rachel Marusinec, et al.
Biophysical Journal|March 16, 2011
Characterization of cytoplasmic Gag-gag interactions by dual-color z-scan fluorescence fluctuation spectroscopyKeir H Fogarty, Yan Chen, Iwen F Grigsby, et al.
ACS Chemical Biology|February 23, 2021
Inhibiting HTLV-1 Protease: A Viable Antiviral TargetGordon J Lockbaum, Mina Henes, Nathaniel Talledge, et al.
Journal of Molecular Biology|May 16, 2017
Single-Strand Consensus Sequencing Reveals that HIV Type but not Subtype Significantly Impacts Viral Mutation Frequencies and SpectraJonathan M O Rawson, Daryl M Gohl, Sean R Landman, et al.
Antimicrobial Agents and Chemotherapy|February 3, 2016
5-Azacytidine Enhances the Mutagenesis of HIV-1 by Reduction to 5-Aza-2'-DeoxycytidineJonathan M O Rawson, Michele B Daly, Jiashu Xie, et al.
Journal of Molecular Biology|May 7, 2023
HIV-2 Immature Particle Morphology Provides Insights into Gag Lattice Stability and Virus MaturationNathaniel Talledge, Huixin Yang, Ke Shi, et al.
Pageof 11